Rogosin Institute Inc is located in New York, NY. The organization was established in 2000. According to its NTEE Classification (E05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Health Care and related organizations. As of 12/2021, Rogosin Institute Inc employed 515 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Rogosin Institute Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Rogosin Institute Inc generated $118.1m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 3.0% each year. All expenses for the organization totaled $119.7m during the year ending 12/2021. While expenses have increased by 3.3% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO PROVIDE THE HIGHEST QUALITY COMPREHENSIVE CARE FOR PEOPLE WITH KIDNEY DISEASE USING A MULTIFACETED INTEGRATIVE APPROACH THAT EMPHASIZES INNOVATIVE TREATMENT OPTIONS AND EDUCATION.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DIALYSIS FACILITIES: PROVIDES IN-CENTER AND HOME HEMODIALYSIS AND PERITONEAL DIALYSIS SERVICES FOR SOME 1,500 PATIENTS WITH KIDNEY FAILURE (END-STAGE KIDNEY DISEASE) THROUGH EIGHT CENTERS IN NEW YORK CITY (BROOKLYN, MANHATTAN AND QUEENS).
IMMUNOGENETICS AND TRANSPLANTATION CENTER:A HISTOCOMPATIBILITY LABORATORY THAT PERFORMS TISSUE TYPING EVALUATIONS TO FACILITATE ORGAN TRANSPLANTATION.
RESEARCH: A BROAD BASIC SCIENCE AND CLINICAL RESEARCH PROGRAM STUDIES ALL ASPECTS OF KIDNEY DISEASE AND RENAL REPLACEMENT THERAPY (DIALYSIS AND KIDNEY TRANSPLANTATION) AND DEVELOPS AND/OR TESTS NEW THERAPEUTIC MODALITIES, INCLUDING THOSE FOR KIDNEY DISEASE, DIABETES, LIPID DISORDERS AND CARDIOVASCULAR DISEASE, AS WELL AS CANCER.
THE CENTER HEALTH ACTION POLICY W.K. KELLOGG FOUNDATION RECEIVED GRANTS AND CONTRIBUTION REVENUE OF $16,900 IN 2021.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Stuart D Saal MD VP Nephrology/consultive Svcs | OfficerTrustee | 35 | $534,184 |
Bruce R Gordon MD Evp/strategy | OfficerTrustee | 35 | $466,930 |
Jeffrey Silberzweig MD VP Dialysis Services/physician | OfficerTrustee | 35 | $455,657 |
Vijay K Sharma Lab Director | Officer | 35 | $375,651 |
Allyson Z Pifko RN Evp/chief Operating Officer | Officer | 35 | $350,097 |
Alan S Perlman Physician | 35 | $349,175 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Cbm Solutions Llc Housekeeping Services | 12/30/21 | $482,800 |
Ernst & Young Llp Professional Services | 12/30/21 | $360,180 |
M Group Consulting Llc Mgmt. Consultants | 12/30/21 | $253,836 |
Abelman Frayne & Schwab Legal Services | 12/30/21 | $172,193 |
Ka Investigations - Security Llc Security Guard | 12/30/21 | $155,581 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $64,772 |
Related organizations | $0 |
Government grants | $239,000 |
All other contributions, gifts, grants, and similar amounts not included above | $6,028,513 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $6,332,285 |
Total Program Service Revenue | $107,909,923 |
Investment income | $2,209,000 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $131,845 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $118,085,739 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $16,900 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $5,151,449 |
Compensation of current officers, directors, key employees. | $955,155 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $48,504,110 |
Pension plan accruals and contributions | $1,110,824 |
Other employee benefits | $9,468,887 |
Payroll taxes | $2,486,999 |
Fees for services: Management | $2,420,152 |
Fees for services: Legal | $413,954 |
Fees for services: Accounting | $360,180 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $3,327,537 |
Advertising and promotion | $153,384 |
Office expenses | $547,974 |
Information technology | $578,721 |
Royalties | $0 |
Occupancy | $10,554,956 |
Travel | $228,355 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $932,224 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $4,074,041 |
Insurance | $1,232,440 |
All other expenses | $77,811 |
Total functional expenses | $119,698,006 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $4,808,874 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $2,791,875 |
Accounts receivable, net | $17,691,516 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $718,694 |
Prepaid expenses and deferred charges | $265,928 |
Net Land, buildings, and equipment | $27,536,381 |
Investments—publicly traded securities | $22,285,449 |
Investments—other securities | $205,927 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $6,178,118 |
Total assets | $82,482,762 |
Accounts payable and accrued expenses | $9,875,932 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $10,919,465 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $19,702,791 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $23,477,733 |
Total liabilities | $63,975,921 |
Net assets without donor restrictions | $15,146,632 |
Net assets with donor restrictions | $3,360,209 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $82,482,762 |
Over the last fiscal year, Rogosin Institute Inc has awarded $776,653 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
Battle Creek, MI PURPOSE: NEW PATHWAYS TO HEALTH | $466,141 |
Bayport, NY PURPOSE: Problem Solving for Better Health Program | $310,512 |
Over the last fiscal year, we have identified 19 grants that Rogosin Institute Inc has recieved totaling $2,219,856.
Awarding Organization | Amount |
---|---|
Starr Foundation New York, NY PURPOSE: STUART SAAL ENDOWED RESEARCH FUND | $1,000,000 |
Llewellyn Family Foundation New York, NY PURPOSE: TO SUPPORT A WELLNESS EDUCATION CENTER WHICH SEEKS TO BUILD EDUCATION & AWARENESS ABOUT KIDNEY HEALTH | $700,000 |
Llewellyn Family Foundation New York, NY PURPOSE: TO SUPPORT A WELLNESS EDUCATION CENTER WHICH SEEKS TO BUILD EDUCATION & AWARENESS ABOUT KIDNEY HEALTH | $400,000 |
Henry Ford Ii Fund Detroit, MI PURPOSE: ANNUAL APPEAL | $25,000 |
American Online Giving Foundation Inc Newark, DE PURPOSE: GENERAL SUPPORT | $20,994 |
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $20,500 |
Beg. Balance | $21,439,982 |
Earnings | $1,943,840 |
Admin Expense | $90,736 |
Other Expense | $875,283 |
Ending Balance | $22,417,802 |
Organization Name | Assets | Revenue |
---|---|---|
Rogosin Institute Inc New York, NY | $82,482,762 | $118,085,739 |
Bill & Melinda Gates Medical Research Institute Cambridge, MA | $277,647,725 | $216,748,532 |
District Council 47 Health And Welfare Fund Philadelphia, PA | $25,561,156 | $78,113,094 |
New York Ehealth Collaborative Inc New York, NY | $53,726,005 | $88,430,287 |
Guttmacher Institute Inc New York, NY | $76,905,675 | $37,459,523 |
Cbset Inc Lexington, MA | $14,994,473 | $24,232,593 |
Ibpat District Council No Ii Health Fund Wallingford, CT | $42,564,448 | $17,002,734 |
New York Academy Of Medicine New York, NY | $83,761,526 | $11,379,075 |
United Hospital Fund Of New York New York, NY | $118,804,052 | $10,406,800 |
District Council 1707 Health And Insurance Fund New York, NY | $11,584,860 | $8,948,840 |
Center For Health Care Strategies Inc Hamilton, NJ | $9,820,920 | $6,350,518 |
Massachusetts Health Data Consortium Inc Waltham, MA | $2,199,626 | $5,057,188 |